ASENT invites you to attend this FREE Virtual Networking Event where we speak with members who have made recent career transitions between Academia, Government, and Industry. Connect with these and other leaders in neurology and neuroscience to gain clarity or share your wisdom on these career transitions.
Join in a short moderated discussion with our guest speakers (see bios below) followed by Q&A and networking.
GUEST SPEAKERS
Dietrich Haubenberger, M.D., MHSc, FAAN
Dr. Dietrich Haubenberger is Executive Medical Director, Clinical Development and Translational Medicine at Neurocrine Biosciences. Before transitioning to this industry-position in January 2019, Dr. Haubenberger served as Director of the Clinical Trials Unit at the Intramural Research Program and Assistant Clinical Director for Clinical Research at the National Institute of Neurological Disorders and Stroke of the National Institutes of Health in Bethesda, MD, USA. Dr. Haubenberger received his medical degree and training as neurologist at the Medical University of Vienna, Austria, followed by a tenure track position to become Associate Professor of Neurology in 2014.
Dr. Haubenberger’s research focuses on the area of movement disorders, where he is an expert in tremor disorders. He published in the field of clinical genetics, neurophysiology as well as outcome measures research. At NINDS, Dr. Haubenberger conducted clinical trials in patients with Essential Tremor, and his current work focuses on the exploration of the neurophysiology of Essential Tremor as well as the neurophysiological correlates of therapeutic interventions in Essential Tremor.
Codrin Lungu, M.D., FAAN
Dr. Codrin Lungu is Clinical Development Lead, Neuroscience at Bristol Meyers Squibb. Prior to transitioning to industry in 2022, Dr. Lungu served as Program Director in the Division of Clinical Research in the National Institute of Neurological Disorders and Stroke of the National Institutes of Health in Bethesda, MD, USA. Dr. Lungu received his medical degree at Gr T Popa University of Medicine and Pharmacy in Iasi, Romania. Then following residency did a movement disorders fellowship at Harvard Medical School followed by a second movement disorders fellowship at NINDS.
Dr. Lungu is a board-certified neurologist, specializing in movement disorders, and has additional training in research methodology, clinical trial design, deep brain stimulation mechanisms, and management and neurotoxin therapy. Dr. Lungu established the first NIH Deep Brain Stimulation (DBS) program, and has led the NIH Botulinum Toxin clinic, and conducts collaborative research in several areas related to movement disorders. He leads research programs for, among others, imaging biomarkers in Parkinson’s disease, objective diagnostic and assessment measures, and therapeutic clinical trials.
MODERATOR
Ludy Shih, M.D., M.M.Sc.
Dr. Ludy Shih received her MD from the University of California School of Medicine, Los Angeles and completed her internship, neurology residency, and movement disorders fellowship at Harvard Medical School/Beth Israel Deaconess Medical Center (BIDMC) and completed a master’s in clinical investigation through the Harvard-MIT Health Sciences and Technology Clinical Investigator Training Program. She has been an active clinical investigator in Parkinson's disease and essential tremor throughout her career. In addition, she worked at Biogen and Vertex Pharmaceuticals in early stage clinical development, designing studies for Parkinson's disease and genetic movement disorders. She is a Fellow of the American Academy of Neurology, and the American Neurological Association, and serves as Associate Editor at Annals of Clinical and Translational Neurology. She has been as a member of ASENT since 2017 and has served as a member as well as co-chair of the Scientific Program Committee and currently serves as ASENT’s President.
